East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Dr. Raman has succeeded Victoria Richon
Since its launch, the medical devices park in Sultanpur has received overwhelming response with more than 50 companies lining up to set up their manufacturing or research and development units
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The company plans to expand its portfolio in regulated markets aggressively
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
The company plans to enter the EU markets in FY22
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
